Hualan Biological Engineering (SZSE:002007) Interest Expense : ¥-14 Mil (TTM As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hualan Biological Engineering's interest expense for the three months ended in Mar. 2024 was ¥ -5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-14 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hualan Biological Engineering's Operating Income for the three months ended in Mar. 2024 was ¥ 250 Mil. Hualan Biological Engineering's Interest Expense for the three months ended in Mar. 2024 was ¥ -5 Mil. Hualan Biological Engineering's Interest Coverage for the quarter that ended in Mar. 2024 was 55.62. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hualan Biological Engineering Interest Expense Historical Data

The historical data trend for Hualan Biological Engineering's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering Interest Expense Chart

Hualan Biological Engineering Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-7.08

-4.97

-21.73

-30.27

-13.17

Hualan Biological Engineering Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-3.74	-5.19	-3.47	-0.77	-4.50

Hualan Biological Engineering Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-14 Mil.

Hualan Biological Engineering (SZSE:002007) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hualan Biological Engineering's Interest Expense for the three months ended in Mar. 2024 was ¥-5 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥250 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥9 Mil.

Hualan Biological Engineering's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	250.475	/	-4.503
	=	55.62

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Hualan Biological Engineering Inc has enough cash to cover all of its debt. Its financial situation is stable.

Hualan Biological Engineering (SZSE:002007) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. A1 Hualan Avenue, Henan Province, Xinxiang, CHN, 453003

Website

http://www.hualanbio.com

Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

Executives

An Kang	Directors, executives
Pan Ruo Wen	Executives
An Wen Qi	Executives
Wang Qi Ping	Directors, executives
Fan Bei	Directors, executives
Ma Xiao Wei	Executives
Xie Jun Min	Directors, executives
Zhang Bao Xian	Executives
Lv Cheng Yu	Securities Affairs Representative
Zhang Jin Gang	Independent director
Wang Li Ting	Independent director
Ma Li	Supervisors
Sun Zhen Guo	Supervisors
Chen Lei Shan	Supervisors
Yang Bao Ping	Supervisors

Hualan Biological Engineering (SZSE:002007) Headlines

No Headlines